Alpha1Health.com | Information for the New Alpha-1 Patient | Patient Brochure

Alpha-1 Kits and Brochures

Download Patient Brochure

ARALAST

ARALAST

Choose a therapy that offers you the support you need.

 

Alpha1Health.com Survey

Take the Alpha1Health.com Survey

Take our survey to help us best meet the needs of the Alpha-1 community.

 

ARALAST Patient Education Kit

patient education kit

The new ARALAST Patient Education Kit is designed to help people living with AAT deficiency*. Baxter is pleased to provide this packet of useful information about the diagnosis, treatment, and management of this condition as another service to the Alpha-1 community.

*Also known as Alpha-1, alpha-1 antitrypsin deficiency, AATD, A1-PI deficiency, alpha-1 proteinase deficiency, A1AD, or hereditary or genetic emphysema.

In the kit, you will find a wealth of print materials to help you with all aspects of living with Alpha-1, including these booklets:

  • Getting Started with Augmentation Therapy
  • About Alpha-1 Antitrypsin (AAT) Deficiency
  • Reimbursement Q & A
  • The ARA-ASSIST Program

Plus, the kit includes a Health Diary and a CD of relaxation music.

order kit

You may order a Patient Education Kit online or by phone at 1-866-ARALAST (272-5278).

Alpha-1 Antitrypsin (AAT) Deficiency: What it means and what you can do

Patient Brochure

This booklet is aimed at patients and families curious to learn more about Alpha-1. This guide has information for everyone, including those considering testing, those recently diagnosed, and those just looking for more information on Alpha-1.

The brochure covers the following topics:

  • What is AAT deficiency?
  • The screening and testing process
  • What treatment might your doctor recommend?
  • AAT augmentation with ARALAST [Alpha1-Proteinase Inhibitor (Human)]
  • Who you can contact for additional help
  • Taking charge
  • A helpful glossary of terms
Order Brochure

You may order the Patient Brochure online or by phone at 1-866-ARALAST (272-5278).

You may also download a copy of the brochure.

ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

adobe reader To view PDF, you will need Adobe® Acrobat® Reader® software.